Prof. Dr. Matthias Beckmann

Lehrstuhl für Geburtshilfe und Frauenheilkunde

Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer (2024) Gaß P, Thiel FC, Häberle L, Ackermann S, Theuser AK, Hummel N, Boehm S, et al. Journal article A content-based review of mobile health applications for breast cancer prevention and education: Characteristics, quality and functionality analysis (2024) Altmannshofer S, Flaucher M, Beierlein M, Eskofier B, Beckmann M, Fasching P, Hübner H Journal article, Review article Perinatal Outcome in Pregnant Women With Isolated Oligohydramnios Diagnosed With the Single Deepest Pocket Method (2024) Dammer U, Pretscher J, Weiss C, Schneider M, Faschingbauer F, Beckmann M, Kehl S Journal article Impact of the Corona Pandemic on Cervical Cancer Screening Assessment (2024) Stübs F, Behrens A, Seibold A, Adler W, Geppert CI, Hartmann A, Knöll A, et al. Journal article Spatial expression of claudin 18.2 in matched primaries and metastases of tubo-ovarian carcinoma of all subtypes (2024) Wagner P, Gaß P, Pöschke P, Eckstein M, Gloßner L, Hartmann A, Beckmann M, et al. Journal article Ureterocele as differential diagnosis of hydrosalpinx-an interesting case from the clinical practice (2024) Psilopatis I, Beckmann M, Emons J, Schulmeyer C Journal article Bedeutung der parametrischen und molekularen Bildgebung für das therapeutische Management des Mammakarzinoms (2024) Hack C, Wetzl M, Schmidt D, Beckmann M Journal article Impact of CCND1 amplification on the prognosis of hormone receptor–positive, HER2-negative breast cancer patients—correlation of clinical and pathological markers (2024) Hanf D, Fasching P, Gaß P, Beckmann M, Hack C, Heindl F, Häberle L, et al. Journal article Comparative assessment of breast volume using a smartphone device versus MRI (2024) Behrens A, Hübner H, Häberle L, Stamminger M, Zint D, Heindl F, Emons J, et al. Journal article A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. (2024) Cuba L, Dürr P, Geßner K, Häcker B, Fietkau R, Siebler J, Pavel ME, et al. Journal article